Phase Ii Neoadjuvant Study Of Gdc-9545+Palbociclib (Palbo) Vs Anastrozole (A) Plus Palbo In Postmenopausal Women With Estrogen Receptor-Positive, Her2-Negative, Untreated Early Breast Cancer (Er+/Her2-Ebc)
CANCER RESEARCH（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要